References
- TurkdoganDToplanSKarakocYLipid peroxidation and antioxidative enzyme activities in childhood epilepsyJ Child Neurol200217967367612503643
- HamedSAAbdellahMMTrace elements and electrolytes homeostasis and their relation to antioxidant enzyme activity in brain hyperexcitability of epileptic patientsJ Pharmacol Sci200496434935915599105
- HermannBPSeidenbergMBellBWoodardARuteckiPShethRComorbid psychiatric symptoms in temporal lobe epilepsy: association with chronicity of epilepsy and impact on quality of lifeEpilepsy Behav20001318419012609152
- HardenCLThe co-morbidity of depression and epilepsy. Epidemiology, etiology, and treatmentNeurology200259S485512270969
- AhernTHJavorsMAEaglesDAThe effect of chronic norepinephrine transporter inactivation on seizure susceptibility in miceNeuropsychopharmacol20052721319
- BlierPDe MontignyCCurrent advances and trends in the treatment of depressionTrends Pharmacol Sci1994152202267940983
- ArtigasFSelective serotonin/noradrenaline reuptake inhibitors (SNRIs)CNS Drugs19947989
- VetulaniJNalepaIAntidepressants: past, present and futureEur J Pharmacol200040535136311033340
- DelgadoPLPriceLHHeningerGRCharneyDSNeurochemistry of Affective DisordersHandbook of Affective DisordersPaytkelESLivingston, NYChurchill1992219253
- DeakinBDursunSOptimizing antidepressant treatment: efficacy and tolerabilityInt Clin Psychopharmacol200217Suppl 1S132412369607
- DikeosDGPapadimitriouGNGenetic investigation of dopamine and GABA in mood disordersAnn Gen Hosp Psychiatry20032S83
- PrueterCNorraCMood disorders and their treatment in patients with epilepsyJ Neuropsychiatry Clin Neurosci2005171202815746479
- BuckleyNAMcManusPRFatal toxicity of serotoninergic and other antidepressant drugs: analysis of United Kingdom mortality dataBr Med J20023251332133312468481
- MontgomerySALoftHSanchezCEscitalopram (S-enantiomer of citalopram): clinical efficacy and onset of action predicted from a rat modelPharmacol Toxicol200188528228611393591
- SiddiquiANazmiAKarimSKhanRPillaiKPalKEffect of Melatonin and Valproate In Epilepsy and DepressionInd J Pharmacol200133378381
- DavidDBourinMJegoGPrzybylskiCJollietPGardierAEffects of acute treatment with paroxetine, citalopram and venlafaxine in vivo on noradrenaline and serotonin outflow: a microdialysis study in Swiss miceBr J Pharmacol200314061128113614530210
- BenjaminJIwataRHazalettJKinetics of entry of proteins into the myelin membraneJ Neurochem19783110771085702136
- GutteridgeJMQuinlanGJMalondialdhyde formation from lipid peroxides in the thiobarbituric acid test: the role of lipid radicals, iron salt and metal chelatorsJ Appl Biochem198354–52932996679543
- GunawanSWaltonNTreimanDHigh performance liquid chromatography determination of selected amino acids in rat brain by precolumn derivatization with phenylisothiocyanateJ Chroma19905031177187
- MontgomerySAAntidepressants and seizures: emphasis on newer agents and clinical implicationsInt J Clin Pract200559121435144016351676
- RossettiVLombardADetermination of glutamate decarboxylase by high-performance liquid chromatographyJ Chromatogr B19966816367
- BradfordMMA rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnal Biochem197672248254942051
- DaileyJWNaritokuDKAntidepressants and seizure: clinical anecdotes overshadow neuroscienceBiochem Pharmacol199652132313298937441
- TrimbleMNon-monoamine oxidase inhibitor antidepressants and epilepsy: a reviewEpilepsia197819241250354920
- EdwardsJGAntidepressants and convulsionsLancet197921368136992708
- SkowronDMStimelGLAntidepressants and the risk of seizuresPharmacotherapy19921218221549533
- RosensteinDLNelsonJCJacobsSCSeizures associated with antidepressants: a reviewJ Clin Psychiatry1993542892998253696
- KannerAMThe behavioral aspects of epilepsy: an overview of controversial issuesEpilepsy Behav20011101105
- BrambillaPPerezJBaraleFSchettiniGSoaresJCGABAergic dysfunction in mood disordersMol Psychiatry20038872173712888801
- ShinsukeWAkifumiINobumasaKTadafumiKPossible relationship between mitochondrial DNA polymorphisms and lithium response in bipolar disorderThe International Journal of Neuropsychopharmacology2003642142410.1017/S146114570300377814604458
- PettyFKramerGLFultonMMoellerFGRushAJLow plasma GABA is a trait-like marker for bipolar illnessNeuropsychopharmacology1993921251328216695
- SanacoraGMasonGFRothmanDLKrystalJHIncreased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitorsAm J Psychiatry2002159466366511925309
- KuruvillaAUretskyNEffect of sodium valproate on motor function regulated by the activation of GABA receptorsPsychopharmacol198172167172
- SunandaBSShankaranarayanaRRajuTRChronic restraint stress impairs acquisition and retention of spatial memory taskCurrent Science2000791115811584
- GrilloCAPiroliGGRosellDRHoskinEKMcewenBSReaganLPRegion specific increases in oxidative stress and superoxide dismutase in the hippocampus of diabetic rats subjected to stressNeuroscience2003121113314012946706
- SudhaKRaoAVRaoAOxidative stress and antioxidants in epilepsyClinica Chimiva Acta20013031924
- ScharfmanHESollasALBergerREGoodmanJHElectrophysiological evidence of monosynaptic excitatory transmission between granule cells after seizure-induced mossy fiber sproutingJ Neurophysiol2003902536254714534276
- AndersenBBMikkelsenMVesteragerADamMKristensenHBPedersenBNo influence of the antidepressant paroxetine on carbamazepine, valproate and phenytoinEpilepsy Res1991102–32012041840138
- LauterbachEMendezMPsychopharmacological neuroprotection in neurodegenerative diseases, part III: criteria-based assessment: A report of the ANPA Committee on ResearchJ Neuropsychiatry Clin Neurosci200123324226021948886